A detailed history of California State Teachers Retirement System transactions in Arcellx, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 31,167 shares of ACLX stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,167
Previous 32,064 2.8%
Holding current value
$2.61 Million
Previous $1.77 Million 47.09%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$50.91 - $86.61 $45,666 - $77,689
-897 Reduced 2.8%
31,167 $2.6 Million
Q2 2024

Aug 14, 2024

BUY
$49.74 - $66.98 $125,145 - $168,521
2,516 Added 8.51%
32,064 $1.77 Million
Q1 2024

May 15, 2024

SELL
$51.85 - $73.49 $135,328 - $191,808
-2,610 Reduced 8.12%
29,548 $2.06 Million
Q4 2023

Feb 13, 2024

SELL
$31.75 - $57.99 $52,895 - $96,611
-1,666 Reduced 4.93%
32,158 $1.78 Million
Q3 2023

Nov 14, 2023

SELL
$31.51 - $37.4 $1.64 Million - $1.95 Million
-52,189 Reduced 60.68%
33,824 $1.21 Million
Q2 2023

Aug 21, 2023

BUY
$27.49 - $46.9 $1.69 Million - $2.89 Million
61,534 Added 251.37%
86,013 $2.72 Million
Q1 2023

May 09, 2023

SELL
$26.92 - $33.94 $3.78 Million - $4.76 Million
-140,325 Reduced 85.15%
24,479 $754,000
Q4 2022

Feb 14, 2023

BUY
$17.18 - $33.0 $2.63 Million - $5.05 Million
153,131 Added 1311.84%
164,804 $5.11 Million
Q3 2022

Nov 18, 2022

BUY
$16.67 - $22.04 $124,524 - $164,638
7,470 Added 177.73%
11,673 $219,000
Q2 2022

Aug 15, 2022

BUY
$7.21 - $24.43 $2,487 - $8,428
345 Added 8.94%
4,203 $76,000
Q1 2022

May 16, 2022

BUY
$12.97 - $19.14 $50,038 - $73,842
3,858 New
3,858 $54,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.67B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.